Compound ID | 812
PF-987296
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and penicillin-resistant Streptococcus pneumoniae |
| Description: | Harris C, Barbachyn MR, Vara Prasad JVN, et al. Identification of a new trifluorophenyl oxazolidinone, PF-987296. 46th-Intersci-Conf-Antimicrobial-Agents-Chemother 2006;213 |
| Institute where first reported: | Pfizer, US; Durata (Actavis, USA) |
| Year first mentioned: | 2006 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| Reason dropped: | Has been in preclinical trials since 2006 |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.